Search research articles
Contact Us
Filters
Showing results (131-140 of 174) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2007
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest
Alfredo Falcone, Sergio Ricci, Isa Brunetti, et al.
Vaccine
|
March 18, 2024
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose
Roberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, et al.
The New England Journal of Medicine
|
October 23, 2014
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer
Fotios Loupakis, Chiara Cremolini, Gianluca Masi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2003
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide
Paola Papaldo, Massimo Lopez, Enrico Cortesi, et al.
The Oncologist
|
April 19, 2019
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population
Lucio Crinò, Paolo Bidoli, Angelo Delmonte, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 7, 2020
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223
Orazio Caffo, Viviana Frantellizzi, Marcello Tucci, et al.
NPJ Breast Cancer
|
December 18, 2024
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer
Linda Cucciniello, Eva Blondeaux, Claudia Bighin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2006
Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide?
Paola Papaldo, Gianluigi Ferretti, Serena Di Cosimo, et al.
BJU International
|
June 30, 2018
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme
Ugo De Giorgi, Giacomo Cartenì, Diana Giannarelli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2019
Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer
Francesco Grossi, Carlo Genova, Lucio Crinò, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 174) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2007
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest
Alfredo Falcone, Sergio Ricci, Isa Brunetti, et al.
Vaccine
|
March 18, 2024
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose
Roberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, et al.
The New England Journal of Medicine
|
October 23, 2014
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer
Fotios Loupakis, Chiara Cremolini, Gianluca Masi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2003
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide
Paola Papaldo, Massimo Lopez, Enrico Cortesi, et al.
The Oncologist
|
April 19, 2019
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population
Lucio Crinò, Paolo Bidoli, Angelo Delmonte, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 7, 2020
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223
Orazio Caffo, Viviana Frantellizzi, Marcello Tucci, et al.
NPJ Breast Cancer
|
December 18, 2024
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer
Linda Cucciniello, Eva Blondeaux, Claudia Bighin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2006
Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide?
Paola Papaldo, Gianluigi Ferretti, Serena Di Cosimo, et al.
BJU International
|
June 30, 2018
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme
Ugo De Giorgi, Giacomo Cartenì, Diana Giannarelli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2019
Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer
Francesco Grossi, Carlo Genova, Lucio Crinò, et al.
Page
of 18